{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:38:42Z","timestamp":1760384322403},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1984,12,1]],"date-time":"1984-12-01T00:00:00Z","timestamp":470707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1984,12]]},"DOI":"10.1007\/bf00431470","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T04:30:54Z","timestamp":1100147454000},"page":"572-573","source":"Crossref","is-referenced-by-count":61,"title":["Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)"],"prefix":"10.1007","volume":"84","author":[{"given":"Albert","family":"Wettstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\ufffd","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"553","volume":"11","author":"C Eisdorfer","year":"1980","unstructured":"Eisdorfer C, Cohen D (1980) Diagnostic criteria for primary neuronal degeneration of the Alzheimer's type. J Fam Pract 11:553?557","journal-title":"J Fam Pract"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"13","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) ?Mini Mental State?, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 13:189?198","journal-title":"J Psychiatr Res"},{"key":"CR3","series-title":"Med Probl Pharmacopsychiatr","first-page":"238","volume-title":"NOSIE-30. History and current status of its use in pharmacopsychiatric research","author":"G Honigfeld","year":"1974","unstructured":"Honigfeld G (1974) NOSIE-30. History and current status of its use in pharmacopsychiatric research. Med Probl Pharmacopsychiatr, vol. 7. Karger, Basel, pp 238?263"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2466\/pms.1982.55.3.839","volume":"55","author":"M Regard","year":"1982","unstructured":"Regard M, Straus E, Knapp P (1982) Children's production on verbal and non-verbal fluency tasks. Percept Mot Skills 55:839?844","journal-title":"Percept Mot Skills"},{"key":"CR5","unstructured":"Spiegel R, Azcona A, Wettstein A (1984) First results with RS 86, an orally active muscarinic agonist, in healthy subjects and in patients with dementia. In: RJ Wurtman, SH Corkin, JH Growdon (eds) Alzheimer's disease: Advances in basic research and therapies. Proc. 3rd Meeting Int. Study Group Treatment Memory Disorders Assoc. Aging, Zurich, Switzerland, January 13?15, 1984, pp 391?405"},{"key":"CR6","series-title":"Papers from the 14th CINP Congress, Florence, 1984","volume-title":"Clinical and pharmacological studies in psychiatric disorders","author":"A WEttstein","year":"1984","unstructured":"WEttstein A, K\u00f6ppel-Hefti A, Spiegel R (1984) Therapeutic trial with the muscarinic agonist RS 86 in patients with senile dementia Alzheimer type. In: GD Burrows, TR Norman (eds) Clinical and pharmacological studies in psychiatric disorders. Papers from the 14th CINP Congress, Florence, 1984. John Libbey, London (in press)"},{"key":"CR7","series-title":"Research Progress in Dementia, London, July 6?8, 1983","volume-title":"Performance of patients with Alzheimer's disease treated with RS 86, a direct muscarinic agonist","author":"A Wettstein","year":"1984","unstructured":"Wettstein A, Spiegel R (1984) Performance of patients with Alzheimer's disease treated with RS 86, a direct muscarinic agonist. Research Progress in Dementia, London, July 6?8, 1983. Karger, Basel (in press)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00431470\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T22:39:33Z","timestamp":1554849573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00431470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,12]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1984,12]]}},"alternative-id":["BF00431470"],"URL":"https:\/\/doi.org\/10.1007\/bf00431470","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,12]]}}}